特許訴訟 ― 仲裁及びその他の裁判外紛争解決
About
コストを抑制しつつ、より有利な解決を図る
弊所は、公判及び控訴に持ち込まれたIP紛争の対応に関して、最も高い評判を得ている法律事務所のひとつですが、状況によっては、裁判外紛争処理（ADR）を選択することもあります。目標達成のために、公判の代わりにADRによる訴訟戦略を構築することも多くあります。
実績
Represented CSRC in two arbitrations and one litigation relating to exclusive licenses and patent assignments for patents directed to treating Pompe Disease, a rare genetic disorder that is often fatal if untreated. Secured a $180 million settlement from Genzyme.
01-19-0001-6937; 01-20-0000-5081, AAA
Represented a major U.S. pharmaceutical company in two arbitrations concerning a leading biologic. Finnegan’s client won both arbitrations and, in the second, was awarded its attorney fees.
Represented a U.S. pharmaceutical company in an arbitration with a former consultant and inventor. The dispute involved issues relating to inventorship and ownership, as well as the determination of royalties due under various agreements. The matter settled shortly before the hearing on favorable terms.
Member of team that represented AbbVie Biotechnology Ltd. and Abbott GmbH in a WIPO arbitration related to patent licensing.
WIPOA120712, WIPO
Counsel for Cumberland in ANDA litigation and breach of contract arbitration. Successful outcome in bench trial, arbitration, arbitration fee award, and appeal.
16-1155, -1259, Fed. Cir., Judges Moore, Reyna, Taranto
1:12-cv-03846, N.D. Ill., Judge Pallmeyer
Guided Anoto through a successful European arbitration proceeding to enforce a supply agreement for a critical component of Anoto’s products, and then spearheaded a successful effort to enforce the arbitrator’s decision in the United States.
3:16-cv-06209, N.D. Cal., Judge Tigar
